Last updated: February 19, 2026
Benzphetamine hydrochloride is a central nervous system stimulant approved by the FDA for short-term weight loss management. The drug is available through a limited set of licensed manufacturers, distributors, and compounding pharmacies. Its supply chain is primarily concentrated in regions with strict pharmaceutical regulatory oversight, such as the United States, Europe, and select Asian countries.
Major Suppliers and Manufacturers
Licensed Pharmaceutical Makers
Most benzphetamine hydrochloride is produced by pharmaceutical companies licensed by regulators for prescription manufacturing. The list of producers is limited, with key players including:
- Indivior: Known for producing controlled substances, including formulations containing benzphetamine hydrochloride for prescription use in the US.
- MediChem: A generic drug manufacturer with licenses to produce benzphetamine hydrochloride, primarily for compounding pharmacies.
- Glenmark Pharmaceuticals: Has manufacturing capabilities for controlled substances and may produce benzphetamine hydrochloride for export or regional distribution.
Contract Manufacturing Organizations (CMOs)
Some companies do not market the drug directly but offer contract manufacturing services, including:
- Patheon (Thermo Fisher Scientific): Provides custom synthesis and formulation services for controlled substances.
- Almac Group: Supplies specialty chemicals and controlled pharmaceutical intermediates.
Compounding Pharmacies
In regions with lenient drug regulations, compounding pharmacies assemble benzphetamine hydrochloride formulations using bulk active ingredients supplied by licensed manufacturers. These entities often source from the same high-quality suppliers listed above, but their supply chain can vary.
Chemical Suppliers
Chemical suppliers provide the raw benzphetamine hydrochloride bulk. Access is generally restricted to licensed pharmaceutical companies, though some chemical distributors may supply to authorized entities:
| Supplier Name |
Location |
Regulatory Status |
Notes |
| Sigma-Aldrich (Merck) |
United States, Europe |
Controlled substance license |
Supplies research-grade and pharmaceutical-grade benzphetamine hydrochloride. |
| TCI America |
United States, Japan |
Regulated |
Distributes benzphetamine hydrochloride for research and compounding purposes. |
| LGC Group |
United Kingdom |
Controlled substance license |
Supplies controlled substance APIs, including benzphetamine hydrochloride. |
Regulatory & Import Controls
- United States: Benzphetamine hydrochloride is classified as a Schedule III controlled substance under the Controlled Substances Act. Manufacturer licensing is regulated by the DEA.
- Europe: Drug manufacturers must adhere to EMA guidelines and possess manufacturing and import licenses.
- Asia: Countries such as India and China produce bulk APIs, but export to regulated markets requires compliance with international controls.
Market Dynamics and Supply Chain Risks
- Strict controls on controlled substances limit the number of suppliers.
- Regulatory oversight restricts raw material distribution, often requiring licensing to purchase or manufacture benzphetamine hydrochloride.
- Manufacturing shortages can occur due to regulatory crackdowns, shifts in DEA scheduling, or manufacturing discontinuations.
Summary
Supply of benzphetamine hydrochloride hinges on a small set of licensed pharmaceutical manufacturers, chemical suppliers, and compounding pharmacies. Most raw-active ingredient procurement is restricted to entities possessing proper regulatory licenses. The global supply chain faces oversight challenges that influence availability, especially outside of regulated markets.
Key Takeaways
- Benzphetamine hydrochloride is manufactured by a limited set of licensed pharmaceutical companies.
- Chemical suppliers like Sigma-Aldrich and TCI provide the bulk API under regulatory licenses.
- Distribution and supply are tightly controlled by agencies such as the DEA and EMA.
- Compounding pharmacies source from licensed suppliers, but their supply chains vary.
- Market availability depends on regulatory environments, with potential shortages due to enforcement or manufacturing issues.
FAQs
1. Who are the primary manufacturers of benzphetamine hydrochloride?
Main licensed manufacturers include Indivior, MediChem, and Glenmark Pharmaceuticals, focusing on prescription formulations within regulated markets.
2. How can I obtain benzphetamine hydrochloride legally?
Legal access is limited to licensed healthcare providers and pharmacies with proper DEA licensing for controlled substances.
3. Are there international suppliers for bulk benzphetamine hydrochloride?
Yes, chemical distributors such as Sigma-Aldrich and TCI supply research-grade or pharmaceutical-grade API, primarily serving licensed manufacturers and compounding entities.
4. What regulatory restrictions affect the supply chain?
Benzphetamine hydrochloride is a Schedule III controlled substance in the US; similar classifications exist elsewhere, imposing strict licensing, documentation, and import/export restrictions.
5. Can benzphetamine hydrochloride be sourced through online chemical marketplaces?
Typically, no. Purchase requires compliance with strict licensing and regulatory guidelines; illegal sources often pose significant legal and safety risks.
Citations
- U.S. Drug Enforcement Administration. (2022). Controlled Substances Schedule. [Online] Available at: https://www.deadiversion.usdoj.gov/schedules/ [Accessed: 20 March 2023].
- European Medicines Agency. (2021). Guidelines on the manufacture of controlled substances. EMA/386832/2021.
- Sigma-Aldrich. (2023). Benzphetamine hydrochloride product info. [Online] Available at: https://www.sigmaaldrich.com/ [Accessed: 20 March 2023].
- TCI Group. (2023). Chemical products: Benzphetamine hydrochloride. [Online] Available at: https://www.tciamerica.com/ [Accessed: 20 March 2023].
